Fulcrum Therapeutics Inc (FULC)
7.12
-0.01
(-0.14%)
USD |
NASDAQ |
Apr 26, 16:00
7.12
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Market Cap: 440.98M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 441.60M |
| April 24, 2024 | 450.89M |
| April 23, 2024 | 460.80M |
| April 22, 2024 | 449.03M |
| April 19, 2024 | 423.64M |
| April 18, 2024 | 437.26M |
| April 17, 2024 | 442.84M |
| April 16, 2024 | 458.94M |
| April 15, 2024 | 455.84M |
| April 12, 2024 | 464.51M |
| April 11, 2024 | 483.71M |
| April 10, 2024 | 489.91M |
| April 09, 2024 | 523.35M |
| April 08, 2024 | 523.35M |
| April 05, 2024 | 527.69M |
| April 04, 2024 | 558.04M |
| April 03, 2024 | 565.47M |
| April 02, 2024 | 561.75M |
| April 01, 2024 | 576.62M |
| March 28, 2024 | 584.67M |
| March 27, 2024 | 585.91M |
| March 26, 2024 | 565.47M |
| March 25, 2024 | 584.05M |
| March 22, 2024 | 598.91M |
| March 21, 2024 | 606.35M |
| Date | Value |
|---|---|
| March 20, 2024 | 603.25M |
| March 19, 2024 | 625.55M |
| March 18, 2024 | 626.78M |
| March 15, 2024 | 703.58M |
| March 14, 2024 | 692.44M |
| March 13, 2024 | 703.58M |
| March 12, 2024 | 675.71M |
| March 11, 2024 | 698.63M |
| March 08, 2024 | 686.24M |
| March 07, 2024 | 700.49M |
| March 06, 2024 | 743.22M |
| March 05, 2024 | 678.81M |
| March 04, 2024 | 701.73M |
| March 01, 2024 | 680.67M |
| February 29, 2024 | 632.36M |
| February 28, 2024 | 639.17M |
| February 27, 2024 | 630.50M |
| February 26, 2024 | 602.63M |
| February 23, 2024 | 594.58M |
| February 22, 2024 | 591.48M |
| February 21, 2024 | 591.48M |
| February 20, 2024 | 587.76M |
| February 16, 2024 | 596.86M |
| February 15, 2024 | 582.00M |
| February 14, 2024 | 562.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
100.61M
Minimum
Oct 21 2019
1.248B
Maximum
Sep 20 2021
401.72M
Average
344.26M
Median
Jul 30 2019
Market Cap Benchmarks
| Pfizer Inc | 143.32B |
| NovaBay Pharmaceuticals Inc | 2.351M |
| Palatin Technologies Inc | 29.29M |
| iBio Inc | 6.132M |
| Theriva Biologics Inc | 7.200M |
Market Cap Related Metrics
| PS Ratio | 155.61 |
| Price to Book Value | 1.875 |
| Price | 7.12 |
| Earnings Yield | -22.19% |